Idiopathic pulmonary fibrosis: Disease mechanisms and drug development von Spagnolo, Paolo, Kropski, Jonathan A., Jones, Mark G., Lee, Joyce S., Rossi, Giulio, Karampitsakos, Theodoros, Maher, Toby M., Tzouvelekis, Argyrios, Ryerson, Christopher J.

Volltext

Progression of fibrosing interstitial lung disease von Wong, Alyson W, Ryerson, Christopher J, Guler, Sabina A

Volltext

Use of Mycophenolate Mofetil or Azathioprine for the Management of Chronic Hypersensitivity Pneumonitis von Morisset, Julie, MD, Johannson, Kerri A., MD, Vittinghoff, Eric, PhD, Aravena, Carlos, MD, Elicker, Brett M., MD, Jones, Kirk D., MD, Fell, Charlene D., MD, Manganas, Helene, MD, Dubé, Bruno-Pierre, MD, Wolters, Paul J., MD, Collard, Harold R., MD, FCCP, Ryerson, Christopher J., MD, Ley, Brett, MD

Volltext

Frailty and postoperative outcomes in patients undergoing surgery for degenerative spine disease von Flexman, Alana M., MD, Charest-Morin, Raphaële, MD, Stobart, Liam, MD, Street, John, MD PhD, Ryerson, Christopher J., MD MAS

Volltext

Acute exacerbation of idiopathic pulmonary fibrosis: shifting the paradigm von Ryerson, Christopher J, Cottin, Vincent, Brown, Kevin K, Collard, Harold R

Volltext

Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper von Lynch, David A, Sverzellati, Nicola, Travis, William D, Brown, Kevin K, Colby, Thomas V, Galvin, Jeffrey R, Goldin, Jonathan G, Hansell, David M, Inoue, Yoshikazu, Johkoh, Takeshi, Nicholson, Andrew G, Knight, Shandra L, Raoof, Suhail, Richeldi, Luca, Ryerson, Christopher J, Ryu, Jay H, Wells, Athol U

Volltext

Prevalence and characteristics of progressive fibrosing interstitial lung disease in a prospective registry von Hambly, Nathan, Farooqi, M Malik, Dvorkin-Gheva, Anna, Donohoe, Kathryn, Garlick, Kristopher, Scallan, Ciaran, Chong, Sy Giin, MacIsaac, Sarah, Assayag, Deborah, Johannson, Kerri A, Fell, Charlene D, Marcoux, Veronica, Manganas, Helene, Morisset, Julie, Comes, Alessia, Fisher, Jolene H, Shapera, Shane, Gershon, Andrea S, To, Teresa, Wong, Alyson W, Sadatsafavi, Mohsen, Wilcox, Pierce G, Halayko, Andrew J, Khalil, Nasreen, Cox, Gerard, Richeldi, Luca, Ryerson, Christopher J, Kolb, Martin

Volltext

Clinical Features and Outcomes in Combined Pulmonary Fibrosis and Emphysema in Idiopathic Pulmonary Fibrosis von Ryerson, Christopher J., MD, Hartman, Thomas, MD, Elicker, Brett M., MD, Ley, Brett, MD, Lee, Joyce S., MD, Abbritti, Marta, MD, Jones, Kirk D., MD, King, Talmadge E., MD, Ryu, Jay, MD, FCCP, Collard, Harold R., MD, FCCP

Volltext

Heterogeneity in Unclassifiable Interstitial Lung Disease. A Systematic Review and Meta-Analysis von Guler, Sabina A, Ellison, Kina, Algamdi, Mohmmed, Collard, Harold R, Ryerson, Christopher J

Volltext

A Standardized Diagnostic Ontology for Fibrotic Interstitial Lung Disease. An International Working Group Perspective von Ryerson, Christopher J, Corte, Tamera J, Lee, Joyce S, Richeldi, Luca, Walsh, Simon L F, Myers, Jeffrey L, Behr, Jürgen, Cottin, Vincent, Danoff, Sonye K, Flaherty, Kevin R, Lederer, David J, Lynch, David A, Martinez, Fernando J, Raghu, Ganesh, Travis, William D, Udwadia, Zarir, Wells, Athol U, Collard, Harold R

Volltext

Evaluating fatigue in patients recovering from COVID-19: validation of the fatigue severity scale and single item screening questions von Naik, Hiten, Shao, Selena, Tran, Karen C, Wong, Alyson W, Russell, James A, Khor, Esther, Nacul, Luis, McKay, R Jane, Carlsten, Christopher, Ryerson, Christopher J, Levin, Adeera

Volltext

Unclassifiable interstitial lung disease: A review von Skolnik, Kate, Ryerson, Christopher J.

Volltext

Pathologic separation of idiopathic pulmonary fibrosis from fibrotic hypersensitivity pneumonitis von Wright, Joanne L., Churg, Andrew, Hague, Cameron J., Wong, Alyson, Ryerson, Christopher J.

Volltext

Prevalence and prognosis of unclassifiable interstitial lung disease von RYERSON, Christopher J, URBANIA, Thomas H, COLLARD, Harold R, RICHELDI, Luca, MOONEY, Joshua J, LEE, Joyce S, JONES, Kirk D, ELICKER, Brett M, KOTH, Laura L, KING, Talmadge E, WOLTERS, Paul J

Volltext

Diagnostic potential of genomic blood biomarkers of pulmonary fibrosis in a prospective cohort von He, Daniel, Shannon, Casey P, Hirota, Jeremy A, Ask, Kjetil, Ryerson, Christopher J, Tebbutt, Scott J

Volltext

A contemporary practical approach to the multidisciplinary management of unclassifiable interstitial lung disease von Ryerson, Christopher J, Corte, Tamera J, Myers, Jeffrey L, Walsh, Simon L F, Guler, Sabina A

Volltext

Radiographic Fibrosis Score Predicts Survival in Hypersensitivity Pneumonitis von Mooney, Joshua J., MD, Elicker, Brett M., MD, Urbania, Thomas H., MD, Agarwal, Misha R., PhD, Ryerson, Christopher J., MD, Nguyen, Michelle Linh T., BA, Woodruff, Prescott G., MD, MPH, Jones, Kirk D., MD, Collard, Harold R., MD, FCCP, King, Talmadge E., MD, Koth, Laura L., MD

Volltext

Chest CT Diagnosis and Clinical Management of Drug-related Pneumonitis in Patients Receiving Molecular Targeting Agents and Immune Checkpoint Inhibitors: A Position Paper from the... von Johkoh, Takeshi, Lee, Kyung Soo, Nishino, Mizuki, Travis, William D, Ryu, Jay H, Lee, Ho Yun, Ryerson, Christopher J, Franquet, Tomás, Bankier, Alexander A, Brown, Kevin K, Goo, Jin Mo, Kauczor, Hans-Ulrich, Lynch, David A, Nicholson, Andrew G, Richeldi, Luca, Schaefer-Prokop, Cornelia M, Verschakelen, Johny, Raoof, Suhail, Rubin, Geoffrey D, Powell, Charles, Inoue, Yoshikazu, Hatabu, Hiroto

Volltext

Use of latent class analysis and patient reported outcome measures to identify distinct long COVID phenotypes: A longitudinal cohort study von Wong, Alyson W, Tran, Karen C, Binka, Mawuena, Janjua, Naveed Z, Sbihi, Hind, Russell, James A, Carlsten, Christopher, Levin, Adeera, Ryerson, Christopher J

Volltext

Does Systemic Sclerosis-associated Interstitial Lung Disease Burn Out? Specific Phenotypes of Disease Progression von Guler, Sabina A, Winstone, Tiffany A, Murphy, Darra, Hague, Cameron, Soon, Jeanette, Sulaiman, Nada, Li, Kathy H, Dunne, James, Wilcox, Pearce G, Ryerson, Christopher J

Volltext